Additionally, De Boni et al. reported lower GFAP levels in blood samples from patients experiencing persistent headaches, suggesting that long-COVID-19 headaches might not indicate underlying neuronal damage or neuroinflammation [26]. The gene discussed is GFAP; the disease is COVID-19.